Rhein Chemie

LANXESS’ first production line for tire curing bladders in Asia

LANXESS’ first production line for tire curing bladders in Asia

Friday, 20. November 2015 - New production line for Rhenoshape high-performance tire curing bladders in China
- Comprehensive product portfolio for the tire industry from a single source

Cologne – The LANXESS Rhein Chemie Additives business unit has opened a production line for Rhenoshape tire curing bladders at its Chinese production site in Qingdao. By the investment of a low single-digit million euro amount LANXESS will expand its global production capacity for these high-performance products in a first step by around 10 per cent.

Rhein Chemie Additives is the only global player offering tire manufacturers bladders, release agents and tire marking inks from a single source. With its fourth bladder plant, the company is further strengthening its global production network. “It is our first Rhenoshape production line in Asia and opens up significant growth potential for us. Our customers place high value on their ability to source Rhenoshape bladders locally,” said Philipp Junge, head of Rubber Additives business at Rhein Chemie Additives. China is the world’s largest producer of tires. “We serve international tire manufacturers who produce their innovative tires in China and other Asian countries, such as Japan, Thailand and Malaysia,” Junge said.

The new production line is equipped with state-of-the-art technology to manufacture curing bladders for lightweight commercial vehicle tires and passenger car tires. It leverages the latest findings in bladder technology and provides customers with bladders from compression and injection presses.

Rhein Chemie Additives supplies the tire industry with a broad range of pre-dispersed polymer-bound additives, processing promoters, vulcanization and filler activators, anti-sun check waxes, release agents, tire marking inks and high-performance tire curing bladders.

Cologne, 20. November 2015
bit (2015-00056e)

Forward-Looking Statements

This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.